Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.89 +0.01 (+0.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Notes Payables (2024 - 2026)

Updated

Drugs Made In America Acquisition (DMAA) reported Notes Payables of $350,000 for Q2 2026.

Analysis

Drugs Made In America Acquisition (DMAA) Notes Payables (2024 - 2026) Analysis & Trends

At the end of FY2024, Drugs Made In America Acquisition posted Notes Payables of $662,324.

  • The Q2 2026 figure ranks as the highest quarterly Notes Payables since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn -
2 Spdr Gold Trust 133.82 Bn -424.18 Bn -
3 Blackstone 84.08 Bn 79.01 Bn -
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn
5 Kkr 81.05 Bn 47.53 Bn -
6 Brookfield Asset Management 71.64 Bn 67.88 Bn -
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn
10 Drugs Made In America Acquisition 335.55 Mn 335.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 350,000.00
Mar 31, 2025 60,898.00
Dec 31, 2024 662,324.00
API Access

Drugs Made In America Acquisition Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=DMAA&period=max&api_key=YOUR_API_KEY